Evidence map›Paper›PMID 37708268›Full record

ArticleScience (New York, N.Y.)2023

Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.

Robin J Dart, Iva Zlatareva, Pierre Vantourout, Efstathios Theodoridis, Ariella Amar, Shichina Kannambath, Philip East, Timothy Recaldin, John C Mansfield, Christopher A Lamb and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. γδ T cells in colorectal and liver cancer.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. International journal of molecular sciences · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Robin J Dart *Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.ORCID 0000-0003-3470-8210
Iva Zlatareva *Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.ORCID 0000-0001-8027-8042
Pierre VantouroutPeter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.ORCID 0000-0001-7287-5517
Efstathios TheodoridisPeter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.
Ariella AmarDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Shichina KannambathNational Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Genomics Centre, King's College London, London, UK.
Philip EastBioinformatics and Biostatistics, The Francis Crick Institute, London, UK.ORCID 0000-0001-5801-5713
Timothy RecaldinGammaDelta Therapeutics Ltd., London, UK.ORCID 0009-0005-6333-4053
John C MansfieldTranslational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0003-2490-7750
Christopher A LambTranslational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-7271-4956
Miles ParkesDepartment of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.ORCID 0000-0002-6467-0631
Peter M IrvingDepartment of Gastroenterology, Guy's and St Thomas' Foundation Trust, London, UK.ORCID 0000-0003-0972-8148
Natalie J PrescottDepartment of Medical and Molecular Genetics, King's College London, London, UK.ORCID 0000-0002-5901-7371
Adrian C HaydayPeter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.ORCID 0000-0002-9495-5793
The Francis Crick Institute · GBGuy's and St Thomas' NHS Foundation Trust · GBKing's College London · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBGamma Therapeutics (United States) · USNational Institute for Health Research · GBUniversity of Cambridge · GB

Funding

Medical Research Council FC001093Wellcome Trust 100156Wellcome Trust 106292Wellcome Trust 108745Wellcome Trust FC001003
6 · The paper itself

Abstract

Murine intraepithelial γδ T cells include distinct tissue-protective cells selected by epithelial butyrophilin-like (BTNL) heteromers. To determine whether this biology is conserved in humans, we characterized the colonic γδ T cell compartment, identifying a diverse repertoire that includes a phenotypically distinct subset coexpressing T cell receptor Vγ4 and the epithelium-binding integrin CD103. This subset was disproportionately diminished and dysregulated in inflammatory bowel disease, whereas on-treatment CD103

Indexed as

ButyrophilinsInflammatory Bowel DiseasesReceptors, Antigen, T-Cell, gamma-deltaT-Lymphocyte SubsetsAnimalsAntigens, CDColonCrohn DiseaseHumansIntegrin alpha ChainsIntestinal MucosaMicealpha E integrinsAntigens, CDBTNL8 protein, humanButyrophilinsIntegrin alpha ChainsReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID37708268
PMCPMC7615126
OpenAlexW4386736950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.